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Abstract
Purpose
The purpose of this study was: 1) To compare Resting energy expenditure (REE) in adult
males with Becker’s Muscular Dystrophy (BeMD, n = 21, 39 ±12 years) and healthy controls
(CTRL, n = 12, 37 ±12 years) 2) Determine whether other physiological parameters corre-
late with REE in BeMD, and 3) Compare current prediction methods of REE with measured
REE.
Methods
REE was calculated via indirect calorimetry using continuous, expired gas analysis following
an overnight fast. Fat free mass (FFM) and fat mass were measured by bioelectrical imped-
ance. B-mode ultrasound measured Tibialis Anterior (TA) and Gastrocnemius Medialis
(GM) anatomical cross sectional area (ACSA). The Bone Specific Physical Activity Ques-
tionnaire measured physical activity.
Results
No difference in REE was found between CTRL and BeMD groups (1913 ±203 & 1786 ±324
Kcal respectively). Other physiological comparisons showed increased fat mass (+54%),
decreased TA ACSA (-42%), increased GM ACSA (+25%) as well as reduced respiratory
function (FVC -28%; FEV1−27%) in BeMD adults compared to controls. REE estimated
from prediction equations (Schofield’s) in Muscular Dystrophy were different from measured
REE (P<0.05, bias = -728kcal), while the Mifflin equation was no different from measured
REE (r2 = 0.58, Bias = -8kcal). Within the present BeMD, REE predicted from FFM (REE =
FFM x 34.57–270; r2 = 0.85) and body mass (REE = BM x 15.65 + 421.5; r2 = 0.66), were
not different from measured REE (bias equals 0 and 0.2kcals, respectively)
Conclusions
Despite no differences in REE between CTRL and BeMD adults, increased fat masses high-
lights the requirement for explicit nutritional guidelines, as well as maintenance of physical
activity levels, where possible. Prediction equations are frequently used in clinical settings,
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however these have been shown to be less accurate in BeMD; therefore, the equations pro-
posed here should be used where possible.
1. Introduction
Muscular dystrophy (MD) is a broad group of myogenic recessive muscle disorders, with vari-
able severity [1]. Duchenne (DMD) and Beckers (BeMD) Muscular Dystrophy are character-
ised by the absence or reduced expression of the cytoskeletal protein dystrophin, resulting in
progressive muscle degeneration[2]. Duchenne Muscular Dystrophy (DMD), characterised by
non-functioning dystrophin, is the most severe form of MD, with an estimated incidence of 3
in 100,000 boys [3]. Becker’s muscular Dystrophy (BeMD) evidences partially functioning dys-
trophin, and is therefore a milder yet more variable form of dystrophinopathy, with an inci-
dence of 2 in 100,000 male births [3]. Shimizu-Fujiwara et al [4] estimated that children with
DMD had decreasing physical activity levels, resulting in reduced calorific energy require-
ments, therefore reducing their daily calorific intake needs. In contrast, the variable nature
and relative degree of physical disability within the BeMD population may be less suitable to a
“one size fits all” approach to daily calorific guidelines.
Nutritional support and knowledge of Resting energy expenditure (REE) is essential for
individuals with limited physical activity in order to provide guidance on calorific intake and
to limit excessive weight gain [5]. However, unlike DMD, there are no current studies of REE
or its estimation from anthropometric measures such as body mass or fat free mass in adult
males with BeMD. REE, here defined as the energy used in maintaining bodily functions such
as respiration, circulation, cellular metabolism and body temperature in a fasted, thermo-neu-
tral state [6], is best predicted in healthy population by FFM, with correlations ranging
between 65–90% [7, 8]. In addition, REE can be normalised to FFM to reduce the impact of
body size on REE [9].
In DMD, the loss of FFM is attributed with a lower REE than non-dystrophic controls [10,
11], with the progressive nature of DMD, resulting in the loss of FFM, leads to REE to decrease
with age within DMD [4]. It is likely therefore, that REE will be lower in adults with BeMD,
who also experience a loss of muscle mass. Loss of muscle mass is a consequence of the progres-
sion of MDs, however lower physical activity levels associated with forms of MD may also lead
to increased muscle atrophy [12]. However, there is currently no research available in either
muscle mass or REE in people with BeMD of any age. REE measurements for participants,
along with Physical Activity Levels, would allow daily energy requirements to be calculated [13].
Prediction of REE in clinical practice is fundamental to weight management. Elliot et al.
[14] found Schofield’s prediction equation based upon body mass as the best predictor of REE
in children with DMD (r = 0.6). Alternatively, Shimizu-Fujiwara et al. [4] found both lung
function the and body mass to be the best predictor of REE in DMD (r = 0.51, and 0.45 respec-
tively, age range of 10–37 years). It is well established that reduced REE is attributed to loss of
muscle mass and FFM with ageing in healthy populations [15]. However, the role of muscles
and FFM remains poorly understood in predicting REE in MD. In DMD, psuedohypertrophy
presents in older children, which may influence the observed relationship between muscle size
and REE. However, recent data has shown lower limb muscles from adults with DMD to be
atrophied [16]. Furthermore, data from adults or children with BeMD is limited.
Therefore, the aims of the present investigation were: 1) to compare the REE in adults
with and without Becker’s Muscular Dystrophy, 2) to determine whether other physiologi-
cal parameters correlate with REE in adults with BeMD, for the construction of a more
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Tibialis Anterior; GM, Gastrocnemius Medialis;
FVC, Forced Vital Capacity; FEV1, Forced Expiratory
Volume 1 second.
appropriate prediction equation of REE; and 3) To compare current, anthropometric predic-
tion methods of REE with measured REE. The authors hypothesise that: 1) adult males with
BeMD will have significantly reduced REE compared to age matched controls; 2) FFM and
lower limb muscle ACSA will be the greatest predictors of REE in BeMD; and 3) Current REE
predictions equations are unlikely to be suitable for use in a degenerative condition.
2. Material and Methods
Twelve healthy adult males (age: 37.8 ±11.9 years, range 21–57 years, height: 1.81 ±0.04 m,
Mass: 81.5 ±11.9 Kg, mean ±SD) and 21 men previously diagnosed with BeMD, 9 ambulatory
(able to walk with or without an aid) and 12 non-ambulatory (relies on the use of a wheelchair)
(age: 39 ±12.7 years range 18–60 years, height: 1.79 ±0.05 m, Mass: 87.2± 16.8 Kg) volunteered
to participate in this study. Ethical approval was obtained through the Department of Exercise
and Sport Science Ethics Committee, Manchester Metropolitan University, and all participants
signed informed consent forms prior to participation. All procedures complied with the
World Medical Association Declaration of Helsinki [17].
2.1 Procedures
All participants were tested in a single testing session; the control group were tested at Man-
chester Metropolitan University (Cheshire) and the BeMD group were tested at The Neuro-
muscular Centre (Winsford, UK). The same equipment was used for both population groups,
with the exception of the seated scales for body mass measures in non-ambulatory BeMD par-
ticipants. All participants were fasted for 12 hours prior to testing, also avoiding caffeine and
extensive exercise. All participants were assessed in a seated position to ensure consistency
between ambulatory and non-ambulatory participants. Anthropometric and Bioelectrical
Impedance measurements were performed first, REE was then measured by indirect calorime-
try with a breath-by-breath gas analysis system (Metamax 3B spiroergometer, Cortex, Ger-
many) and analysed using the accompanying software (MetaSoft). Ultrasounds scans were
performed post indirect-calorimetry upon the participant’s self-reported dominant leg using a
portable ultrasound (MyLab25, Esaote Biomedica, Genoa, Italy). FVC, FEV1 and FVC/FEV1
ratio measurements were performed last using a Pneumotrac 6800 digital vitalograph and ana-
lysed using Spirotrac software (Vitalograph, England). Body fat and fat free mass measure-
ments were completed through Bio-Electrical Impedance using a BodyStat 1500 (BodyStat,
England). Both measurement locations were air conditioned, with the ambient temperature
set to 20˚C.
2.1.1 Anthropometric measurements. All participants height was calculated as point to
point (index finger, elbow, shoulder and across midline) span, as to replicate the technique
used on non-ambulatory BeMD participants using a 2m tape measure. In order to account for
the known discrepancy between standing height and arm span measures, a correction was
applied consistent with regression data from adult Caucasian males, the known error of mak-
ing this correction is 3.5% [18]. Participant height is presented as this corrected value. In the
Control group mass was measured by digital scales (Seca model 873, Seca, Germany), BeMD
participants were weighed in a digital seated scales system (6875, Detecto, Webb City, Mo,
USA). The weight of slings, shoes, splints etc. were subtracted from gross weight post weighing
separately.
2.1.2 Body composition measurement. Fat mass and Fat Free Mass were measured using
Bioelectrical Impedance (BIA) (Body STAT, 1500) with adhesive electrodes paced on the right
hand and foot. Two proximal electrodes were placed between the styloid processes of the right
ulna and radius, and between the medial and lateral malleoli of the right ankle. Two Distal
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electrodes were placed on dorsal surfaces of metacarpals and metatarsals. All participants were
measured while seated, and asked to remain still. BIA has previously been used within DMD
populations in previous REE studies [10]. BIA has been shown to be valid and reliable in com-
parison to DEXA, with a Pearson Correlation Coefficient of r = 0.99 in adults of healthy
weight, and r = 0.78 in an overweight population [19, 20]. The following equation was used to
determine Fat Free Mass:
FFM ðkgÞ ¼ Body Mass ðkgÞ   Fat Mass ðkgÞ
Equation 1. Fat Free Mass equation: FFM = Fat Free Mass; kg = kilograms.
Body Mass Index (BMI) was calculated using the following equation [21]:
BMI ðkg=m2Þ ¼ Body Mass ðkgÞ  Height2ðm2Þ
Equation 2. BMI Equation: BMI = Body Mass Index; kg = kilograms; m = metres.
2.1.3 Resting energy expenditure. REE was measured by indirect calorimetry using a low
dead space, low resistance facemask and volume sensor assembly (MetaMax 3B, Cortex, Leipzig,
Germany). Fractional concentrations of O2 and CO2 were measured by electro-chemical cell,
via gas drawn down a capillary line from the facemask. The gas analyser was calibrated accord-
ing to manufacture guidelines before each test, using calibration gases across the expected range
from room air to 16.01% O2, and 3.99% CO2. Gas volumes were measured through a turbine
system attached to the facemask, calibrated using a 3-liter calibration syringe (Hans Rudolph,
Inc., Kansas City, USA), and corrected for ambient conditions (pressure and temperature) prior
to each test.
The use of a facemask to calculate REE has been previously validated against the ventilated
hood technique (r = 0.91, p<0.001) [22]. In addition, reliability tests of the facemask equip-
ment were performed, with participants measured for 30 minutes while in a fasted state across
two separate days at the same time, with the resulting data falling within the Limits of Agree-
ment (LOA) (n = 11. ICC = .87, LOA = +155/-201Kcal) (Fig 1).
All participants undertook a 12 hour fast prior to testing. Participants remained with the
facemasks attached and seated for up to 30 minutes, with measurements of a plateaued period
of breathing taken post 20 minutes. Measurements were taken post 20 minutes because initial
Fig 1. Repeatability of REE in Control Participants (n = 10), Day 1 vs Day 2.
doi:10.1371/journal.pone.0169848.g001
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wearing of the facemask has been shown to increase breathing rate, while a pilot study showed
VO2 to plateau post 20 minutes (Fig 2) [23].
The REE values were recorded using the same equation previously used in REE measure-
ments in DMD participants [4], as seen below:
REE ðKcal=dayÞ ¼ VO2ðSTPDðl=minÞÞ  4:825 ðKcalÞ  60 ðminutesÞ  24 ðhoursÞ
Equation 3. REE Measurement Equation: REE = Resting Energy Expenditure;
Kcal = Kilocalories; VO2 = Oxygen Consumption; STPD = Standard Temperature and Pres-
sure, Dry; l – litres.
Participants were measured post 20 minutes of testing to allow time for Respiratory Quo-
tient (RQ) (ratio of CO2 removed from the body to O2 consumed by the body) to drop below
0.82. Under conditions where participants RQ is 0.82 or lower, the body consumes 4.825kcal
of energy per litre of oxygen [24]. Under normal conditions less than 5% error has been found
using the method of indirect calorimetry [25].
Body size has been shown to significantly alter REE of individuals, via an increase in fat free
mass. Therefore, to normalise for body size the following equation was also used:
REE ðKcal=day=FFMÞ ¼ REE ðKcal=dayÞ  FFM ðkgÞ
Equation 4. REE normalised for FFM: REE = Resting Energy Expenditure;
Kcal = Kilocalories; FFM = Fat Free Mass; kg = kilograms.
2.1.4 Ultrasound. Real-time B-Mode ultrasound (MyLab Gamma, Esaote, Cambridge-
shire, UK) was used for measurements of muscle length (Lm), Anatomical Cross Sectional
Area (ACSA) of the Tibialis Anterior (TA) and Gastrocnemius Medialis (GM) respectively.
ACSA was measured using transverse ultrasound scans (width of probe, 7.5-MHz linear array
probe) at their largest cross-sectional area, 50% of the GM and 30% of the TA [26]. GM Lm
was measured using a tape measure over the skin surface following identification of the visible
origin of the GM at the posterior aspect of the femur to the distal formation of the myotendi-
nous junction by use of sagittal pane ultrasonography. TA Lm was measured by the same tech-
nique from the lateral condyle of the tibia to the musculotendinous junction.
Echoabsoptive tape (Transpore, 3M, USA) was used to project shadows onto the ultrasound
image and provide a positional reference. Strips of tape were placed longitudinally across the
GM and TA at 50% and 30% of muscle length respectively, at approximately 3cm intervals. A
digital recording of the probe moving from the medial to lateral border of the GM and TA was
Fig 2. Pilot data of average REE over time in Control Participants.
doi:10.1371/journal.pone.0169848.g002
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obtained with the probe in a transverse plane. To avoid compression of the muscle, consistent,
minimum pressure was applied. The ultrasound was recorded in real time at 25 frames per sec-
ond (Adobe Premier pro Version 6). At each interval consisting of two reference markers, as
shown by shadows from the echoabsoptive tape, individual images were captured using cap-
turing software (Adobe Premier Elements, version 10). The shadows from the echoapsoptive
markers allowed the images to be aligned along with the contour of the muscle, and the entire
GM and TA ACSA to be recreated in a single image (Fig 3) (Graphic Image Manipulation Pro-
gram, GIMP Development). The ACSA was then measured using digitising software (ImageJ
1.45, National Institutes of Health, USA). This method of ultrasound to measure ACSA has
previously been reported as a valid (0.998) and reliable (0.999) measure in comparison to MRI
[26].
2.1.5 Electronic vitalograph. Forced Vital Capacity (FVC) and Forced Expiratory Vol-
ume in the first second (FEV1) were measured using an electronic spirometer (Pneumotrac,
Vitalograph, Bucks, UK). All participants performed the measurements sitting down to repli-
cate the non-ambulatory BeMD participants. Participants had a nose clip attached and the pro-
tocol was explained to all participants prior to completion of trials. For each trial participants
carried out a maximum inspiratory breath, before breathing out as fast and hard as possible
into the mouthpiece. Participants performed three trials and the best performance was
accepted. The validity of the Electronic vitalograph is well reported for respiratory function
tests in healthy and clinical populations [27].
2.1.6 Resting energy expenditure prediction equations. Two established REE equations
were used in comparison to the measured REE values. The simplified Schofield equation [28]
using just height and mass, previously identified as the best predictor of REE in children and
adolescents with DMD [14]. Alternatively, the Mifflin equation [29] commonly used in healthy
individuals was also used. The Mifflin equation includes measures of mass, height and age.
Fig 3. Example of the reconstruction of the GM (A) and TA (B) for Control (Left) and BeMD (Right)
participants.
doi:10.1371/journal.pone.0169848.g003
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Both equations can be seen below:
REE ¼ ðð17:7mass ðkgÞ þ 657Þ  4:182 1000Þ  239
Equation 5. Schofield Equation: REE = Resting Energy Expenditure (Kcal).
REE ¼ 10mass ðkgÞ þ 6:25 height ðcmÞ   5 age ðyearsÞ
Equation 6. Mifflin Equation: REE = Resting Energy Expenditure (Kcal)
2.1.7 Physical activity levels. The Bone Specific Physical Activity Questionnaire (BPAQ)
is a previously validated, self-administered questionnaire addressing current and previous
physical activity levels. The BPAQ algorithms have been previously described and are based
upon force loading associated in different physical activity and sports [30]. To eliminate inter-
tester variability, BPAQ data was entered and analysed by a single investigator. Activities listed
in the BPAQ Calculator were entered, with remaining activities entered as ‘other’ and there
perceived impact (low, moderate or high). Current physical activity levels were used for analy-
sis (cBPAQ), which reduced levels have previously been correlated with cardiovascular disease
[31]. Although not specifically designed for measurements in individuals with disability, the
BPAQ questionnaire has previously been used in Muscular Dystrophy, and shown to correlate
significantly with disability specific health questionnaires, such as the Physical Activity Scale
for Individuals with Physical Disabilities (PASIPD, [32]). Specifically, within a similar popula-
tion of adults with BeMD the BPAQ and PASIPD was shown to have significant association
(r = 0.71, p =<0.005), and no significant differences between the two physical activity assess-
ment measures (P = 0.404) [33].
2.1.8 Statistical analysis. Data analysis was performed by IBM SPSS Statistics 21 software.
The critical level of statistical significance was set at 5%. Tests for parametricity were per-
formed upon all variables. Reliability of REE measured over two days, was calculated using
Intraclass Correlation Coefficients, and Bland-Altman analysis (Fig 1, and presented in “Meth-
ods” section 2.1.3). Means and standard deviations for all variables can be found in Tables 1, 2
and 3. Independent Student T-Tests were performed between BeMD and Control participants
Table 1. Anthropometric measures from adult males with (BeMD) and without (CTRL) Becker’s muscle dystrophy.
Control BeMD
Combined Ambulatory Non-Ambulatory
N 12 21 9 12
Age (Years) 37.8 ±12.0 39.0 ±12.7 39.9 ±13.3 38.4 ±12.2
Height (cm) 179.6 ±5.0 179.2 ±4.0 177.3 ±3.1 177.1 ±3.4
Body Mass (Kg) 80.7±10.2 87.2 ±16.8* 81.0 ±8.6 92.1 ±19.8†
BMI (Kg/m2) 25.1 ±3.4 27.5 ±4.9* 25.7 ±2.3 29.3 ±6.0†
Ambulatory (% of participants) 100% 43%* 100% 0%†
Body Fat % 21.0 ±7.6 30.1 ±5.23* 27.4 ±3.6 32.1 ±5.3†
Fat mass (Kg) 17.6 ±8.7 27.1 ±10.6* 22.7 ±5.2 30.5 ±12.5†
FFM (Kg) 63.1 ±3.3 59.5 ±8.6* 55.2 ±7.6 62.2 ±8.3†
BPAQ Score (Current PAL) 5.4 ±3.6 0.6 ±0.8* 1.4 ±0.4 0 ±0†
Data are presented as mean (SD)
*denotes significant difference between groups (P<0.05).
† denotes significant difference from ambulatory BEMD.
BeMD = Becker’s Muscular Dystrophy; BMI = Body Mass Index; BPAQ = Bone Specific Physical Activity Questionnaire; P-P = Point to point; FFM = Fat
Free Mass; PAL = Physical Activity Level.
doi:10.1371/journal.pone.0169848.t001
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and ANOVA’s performed between BeMD ambulatory status (Ambulatory and non-ambula-
tory) and control groups, for all variables to find differences. A Two way ANOVA was per-
formed between BeMD age groups (18–40 years vs 41–60 years) for REE. Additionally, Linear
and Multiple Regression Analysis was performed to examine the best predictors of REE in
BeMD participants. Linear regressions are used to develop possible REE Prediction Equations
from measured anthropometric data (FFM, FM etc.). Bland-Altman analysis and explained
variance were then used to compare REE measured in the present study using indirect calo-
rimetry, to previously established Prediction Equations, and those developed within the pres-
ent study.
3. Results
3.1 Anthropometry
BeMD participants were not different in age, height, mass or BMI from CTRL (P>0.05,
Table 1). Fat% and fat mass were 43% and 54% greater in BeMD participants compared to
CTRL, respectively (P<0.05, Table 1). No significant differences were found between groups
for Fat Free Mass. When separated into ambulatory and non-ambulatory groups, significantly
greater Body Mass, BMI, Fat%, Fat (Kg) and FFM were found in the non-ambulatory group
compared to the ambulatory group (P<0.05, Table 1). BPAQ current physical activity level
scores showed BeMD to have 88% lower physical activity than CTRL participants (P<0.05,
Table 1). Furthermore, non-ambulatory BeMD participants were significantly less active than
ambulatory participants were (P<0.01, Table 1).
Table 2. Lower limb muscle size measures from adult males with (BeMD) and without (Control) Becker’s muscle dystrophy.
Control BeMD
Combined Ambulatory Non-Ambulatory
Tibia Length (cm) 44.0 ±1.3 40.8 ±3.0* 41.7 ±2.9 40.2 ±2.8
TA Length (cm) 25.8 ±1.9 21.7 ±3.1* 22.6 ±2.9 21.0 ±3.2
TA ACSA (cm2) 9.9 ±1.9 5.7 ±1.5* 5.6 ±1.2 5.7 ±1.8
GM Length (cm) 24.0 ±2.2 21.3 ±3.8* 21.5 ±2.4 21.2 ±4.7
GM ACSA (cm2) 15.4 ±2.9 19.3 ±9.7* 15.5 ±4.3 22.1 ±11.7†
Data are presented as mean (SD)
*denotes significant difference from control groups (P<0.05).
† denotes significant difference from ambulatory BEMD. TA–Tibialis Anterior; ACSA–Anatomical Cross Sectional Area; GM–Gastrocnemius Medialis.
doi:10.1371/journal.pone.0169848.t002
Table 3. Respiratory function, and resting calorimeter measures from adult males with (BeMD) and without (Control) Becker’s muscle dystrophy.
Control BeMD
Combined Ambulatory Non-Ambulatory
FEV1 (L) 4.2 ± 0.7 3.1 ± 1.2* 3.6 ± 0.6 2.7 ± 1.4
FVC (L) 5.1 ± 0.4 3.6 ± 1.4* 4.3 ± 0.8 3.2 ± 1.5†
FEV1/FVC (%) 83.2 ± 9.7 85.3 ± 8.8 85.1 ± 5.3 85.3 ± 10.7
REE (Kcal/Day) 1913.6 ± 203.2 1786 ± 324.1 1676 ± 246.3 1869 ±352.2
REE (Kcal/Day/FFM) 30.0 ± 2.3 30.0 ± 2.1 30.1 ± 2.2 29.9 ± 2.1
FEV1 –Forced Expiratory Volume in 1st Second; FVC–Forced Vital Capacity; REE–Resting Energy Expenditure; Kcal–Kilocalories; FFM–Fat Free Mass.
Data are presented as mean (SD)
*denotes significant difference between groups (P<0.05).
doi:10.1371/journal.pone.0169848.t003
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The BeMD group had significantly shorter tibia, Ta and GM Length by 7, 15 and 11%
repectively (P<0.05, Table 2). TA ACSA was smaller by 43% in BeMD compared to CTRL
(P<0.05, Table 2). In contrast, BeMD had a 26% larger GM ACSA compared to CTRL
(P<0.05, Table 2).
No difference was found between ambulatory and non-ambulatory BeMD participants for
Tibia Length, TA ACSA, TA length or GM Length (Table 2). Non-ambulatory BeMD partici-
pants showed 30% larger GM ACSA compared to ambulatory BeMD (P<0.05, Table 2).
3.2 Respiratory measures
FVC and FEV1 were 28% and 27% lower for BeMD participants compared to controls, respec-
tively (P<0.05, Table 3). No differences were found between groups for FVC/FEV1 (Table 3).
36% and 37% smaller FVC and FEV1 values were observed for non-ambulatory BeMD com-
pared to ambulatory BeMD (p<0.05, Table 3), however no differences were found in FVC/
FEV1 (p>0.05).
3.3 Energy expenditure
No significant differences were found between BeMD or CTRL groups for REE or REE/FFM
(p>0.05, Table 3). Within BeMD participants, there was no difference between age groups
(18–40 and 41–60 years old) for REE, 1885 Kcal/Day and 1853 Kcal/Day, REE/FFM, 29.22
Kcal/FFM/Day and 30.78 Kcal/FFM/Day, or ambulatory status (Table 4).
Within the BeMD participant’s, linear regressions revealed significant relationships
between four variables and REE (Kcal/day). The strongest correlation was found between FFM
and REE (Kcal/day) (R2 = 0.85; P<0.05; Fig 4). Similarly, there were positive correlations
between body mass (R2 = 0.66; P<0.05; Fig 5), Fat mass (R2 = 0.28; P<0.05; Fig 6) and GM
ACSA (R2 = 0.24; P<0.05; Fig 7) with REE (Kcal/day). Compared to FFM (the strongest pre-
dictor of REE) multiple regression showed no further benefit of including all anthropometric
variables (R2 = 0.87).
Within BeMD participants existing REE prediction equations showed that REE estimated
from mass (the Schofield equation) to be 41% more than the measured REE values (p<0.05;
Table 4). REE estimated from Mass, height and age (the Mifflin equation) was not significantly
different from the measured REE values (p>0.05; Table 4). Based on the present participants,
we found FFM to be the best predictor of REE (Equation 7: REE = 34.57 x FFM—270.5), show-
ing no difference from measured values. Body mass estimates of REE within the present
BeMD participants (Equation 8: REE = Body Mass x 15.652 + 421.15) were also not
Table 4. Prediction Equations correlation with measured REE in Adults with BeMD.
Equation REE (Kcal/Day) Bias (Kcal) Limits of Agreement (-/+(Kcal) Correlation (R2)
Measured 1786 (324) n/a n/a n/a
Schofield et al (1985) 2514 (340)* -728 -1126, -328 0.66
Mifflin et al (1990) 1801 (197) -8 -429, 412 0.58
FFM x 34.572–270.51 1787 (299) 0 -241, 241 0.86
BM x 15.652 + 421.15 1786 (279) 0.02 -362, 362 0.66
Values shown are measured and predicted REE and correlation values (R2).
*Denotes significant difference between measured and estimated REE.
REE = Resting Energy Expenditure; Kcal = Kilocalories; FFM = Fat Free Mass; BM = Body Mass.
doi:10.1371/journal.pone.0169848.t004
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significantly different from measured REE, however not to the extent of the FFM equation.
REE ¼ FFM  34:57   270:51
Equation 7. FFM Based Prediction Equation of REE in BeMD Adults. REE = Resting
Energy Expenditure (Kcal); FFM = Fat Free Mass (Kg).
REE ¼ BM  15:652 þ 421:15
Equation 8. Body Mass Based Prediction Equation of REE in BeMD Adults. REE = Resting
Energy Expenditure (Kcal); BM = Body Mass (Kg).
Fig 4. REE and FFM relationship in BeMD (closed circles) and Control participants (open circles).
FFM = Fat Free Mass; Kg = Kilograms; REE = Resting Energy Expenditure; Kcal = Kilocalories.
doi:10.1371/journal.pone.0169848.g004
Fig 5. REE and Body Mass (Kg) relationship in BeMD (closed circles) and Control (open circles)
participants. Kg = Kilograms; REE = Resting Energy Expenditure; Kcal = Kilocalories.
doi:10.1371/journal.pone.0169848.g005
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3.4 Co-variables
Of the co-variables measured, equations involving body mass and FFM were found to show
strong correlations with measured REE (Body Mass p>0.05; r = 0.81; FFM p>0.05; r = 0.91;
See Table 4). The Mifflin predicted REE was 1801 Kcal/Day±202 and was not significantly dif-
ferent from the measured REE 1786 Kcal/Day±324. In contrast, the Schofield prediction equa-
tion, 2514 Kcal/Day±340, was significantly greater than the measured REE. The REE
prediction equations produced Pearson’s Correlation Coefficients of 0.81 and 0.79 for the
Schofield and Mifflin Equations, respectively. Bland-Altman analysis illustrated the systematic
bias and random error, between the prediction equations and measured REE (Table 4). There
Fig 6. REE and Fat Mass (Kg) relationship in BeMD (closed circles) and Control (open circles)
participants. Kg = Kilograms; REE = Resting Energy Expenditure; Kcal = Kilocalories.
doi:10.1371/journal.pone.0169848.g006
Fig 7. Relationship between GM ACSA and REE in BeMD (closed circles) and Control (open circles)
participants. GM = Gastrocnemius Medialis; ACSA = Anatomical Cross Sectional Area; cm = centimetres;
REE = Resting Energy Expenditure; Kcal = Kilocalories.
doi:10.1371/journal.pone.0169848.g007
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was a 40% greater REE when the Schofield prediction equation was used compared to the mea-
sured REE in BeMD (P<0.05), indicating substantial systematic bias. In contrast, the REE esti-
mated from the Mifflin prediction equation showed no difference from the measured REE
(P>0.05).
4. Discussion
The present study had three main findings, 1) REE was not different between adult males with
and without BeMD; 2) FFM showed the closest association to REE in the BeMD participants;
3) Of the two previously used REE prediction equations, one (using body mass, height and
age) was valid within adult males with BeMD. However (consistent with finding 2) from the
present data, prediction equations based upon FFM were found to be the best predictor of
REE in BeMD. We also present here novel anthropometric and muscle data from adult males
with BeMD, which is somewhat consistent with previous observations from the muscles of
children with MD.
The requirement for nutritional guidelines in MD is particularly relevant given the evi-
denced increased fat mass of those with the condition in the present study and previous [16,
34]. This is likely a result of calorific imbalance [35] and reduced physical activity levels
observed here in adults with BeMD and previously in adults with DMD [36]. Weight gain is
common in adolescents with MD, and often exacerbated by the use of corticosteroid treat-
ment, such as deflazacort and prednisone [37, 38]; however, no participants in the current
study have any history of corticosteroid treatment. Lower body mass has been previously
reported in adults with DMD [16], however this was attributed to the loss of FFM associated
with the condition. In contrast, the current adult BeMD participants presented with a greater
body mass than controls, which is likely to be a combination of maintained FFM,, as well as
increased Fat Mass compared to the controls. The higher fat mass in the present BeMD group
is likely a combination of reduced physical activity (discussed below) and excessive calorific
intake (although calorific intake was not measured in the present study). Based on the present
observations, calorific guidelines using FFM may help to reduce any negative impact on car-
diac function [35] and muscle degradation [37] associated with excessive body fat.
In the present study, within BeMD there was a strong correlation between FFM and REE,
however REE did not differ between any groups. Additionally, no differences were seen
between groups, when REE was normalised for FFM. Consistent with this, the largest correla-
tions between anthropometric measures and REE were found with FFM and BM. Similar to
the non-dystrophic control population, the present study showed that individuals with BeMD
had a daily resting calorific requirement of 1786 Kcal/day. This is in contrast to previous data
from adults with DMD who have been shown to have significantly reduced REE with age [4,
11]. For example, Shimizu-Fujiwara et al. [4] and Gonzalez-Bermejo et al. [11], both reported
REE to be significantly lower than control groups with adult DMD patients presenting with
970–1239 and 1089 Kcal/day [4, 11], respectively. The higher REE in the present study com-
pared to those in the DMD population, is likely a reflection of the less severe nature of BeMD
compared to DMD and their higher FFM compared to DMD. Calorific guidelines for those
with BeMD should therefore, not be based on previous studies in DMD. Where previous stud-
ies have used body mass to estimate REE in MD, REE was predicted to be 2530Kcal/Day using
body mass [14]. These are significantly higher than those measured in the current study (1786
±324 kcal/day) and not only highlights the requirement for nutritional guidelines specific to
BeMD, but is consistent with the lower validity of using body mass estimates of REE over FFM
in the present study.
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Previous DMD studies [4] have used the Schofield prediction equation to estimate REE in
adults, while they also showed FEV1 to be a strong physiological predictor of REE. However,
within the current study the Mifflin equation (commonly used in non-dystrophic populations)
was found to be a more appropriate method of REE prediction in adults with BeMD, and mea-
sures of FFM and BM were shown to be much better physiological predictors of REE then
FEV1. The Schofield [28] prediction method did overestimate REE in BeMD, which may have
implications for daily calorific intakes and long-term health in BeMD. Additively, the wider
confidence intervals of the Mifflin equation and BM equation suggest where possible, FFM is
adopted in future methods for predicting REE in adults with BeMD.
Our findings of a lower FFM in BeMD compared to previous is consistent with previous
measures of lower muscle, and bone mass in BeMD compared to controls [33]. What was
somewhat surprising was the fact that within BeMD, Non-ambulatory participants had higher
FFM than ambulatory BeMD participants. Non-ambulatory participants would be expected to
have reduced FFM (and therefore REE) due to lower physical activity levels [39]. The greater
FFM and GM ACSA in the present non-ambulatory BeMD participants may represent psue-
dohypertrophy, an inflammatory response from increased muscle degeneration previously
reported in adolescents with DMD [40].. It is possible, given the similar loci of impairments
within the dystrophin protein [1], that the more severe forms of BeMD, specifically the non-
ambulatory participants in the present study, may present with pseudohypertrophy similar to
adolescents with DMD.
Despite the well-established symptoms and progression of the condition [34, 41], there is at
present very few studies comparing neuromuscular and respiratory measures between adult
males with and without BeMD. Our respiratory data (FEV1, FVC, and FEV1/FVC) is consis-
tent with others who have reported relative impairments in adults with MD [42]. We have
observed significant impairments in FEV1 and FVC in BeMD compared to controls. Respira-
tory function, and its impact on sleep apnoea (an obstructive condition amplified by excessive
weight) and nocturnal hypoventilation (airway restriction associated with muscle fatigue
against abdominal pressure when supine), has long been recognised in DMD, and highly asso-
ciated with quality of life and life expectancy [43, 44]. Future studies, particularly intervention
studies, should focus on respiratory impairment and their responses in adults with BeMD.
Measures of TA ACSA in the present study show that BeMD were smaller than control par-
ticipants are similar to those reported previously [33], and aligns itself with the classical muscle
wasting definition of the condition; GM ACSA has been commented upon previously, and is
heavily influenced by the non-ambulatory nature of this sample [16]. It is possible that similar
to adults with DMD [16], the progression of BeMD may show atrophy within the GM, how-
ever these are not presented in the current adults who are all aged< 55 years. More longitudi-
nal studies are required, tracking changes in muscle, FFM and BM to further understand the
condition.
Within the present study there were two primary limitations, 1) the use of BIA, and 2) no
measure of calorific intake. BIA remains unvalidated in BeMD, however it has been shown
previously to be a strong predictor of FFM in children with DMD and was suggested as a
tool to measure changes in nutritional status [45]. We recently addressed similar concerns
when measuring bone health [33] and noted that contractures, joint stiffness and lower
mobility in general make more stringent measures of FFM, such as DEXA, difficult to
obtain in MD. However, in terms of guidelines for calorific intake, we also feel that BIA is a
more available and cost effective tool than the alternative [46]. In addition, calorific intake
and calorific energy expenditure, through physical activity, were not measured in the cur-
rent study. Although this does not impact on our main findings in terms of REE, knowledge
of calorific intake and expenditure would allow us to make stronger conclusions regarding
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the mechanisms and determinants of higher fat mass in BeMD compared to controls in the
present study.
The main clinical implication from our present study is that fat mass and BMI are higher in
BeMD than controls, and prediction equations based on anthropometric measures may be
useful in addressing this higher fat mass. Evident from our anthropometric data, we have
observed that fat mass, BMI and relative fat mass is higher in adults with BeMD, particularly in
non-ambulatory participants. Combined with our finding that there is no difference in REE
from controls, greater dietary considerations and advice are needed for adults with BeMD in
order to control for weight gain, and any subsequent co-morbidities associated with this
accrued fat mass. Specific to the present data, our prediction equation using FFM may be use-
ful in addressing some of the issues associated with higher body fat and fat mass observed in
the present BeMD participants; however longitudinal data on weight management and dietary
requirements in BeMD is required.
In conclusion, while no direct differences were found in measured REE between adults
with and without BeMD, the increased levels of fat mass in the BeMD group, and large differ-
ences found in previously established REE prediction equations highlight the requirement for
specific nutritional guidelines within BeMD adults. The strong correlation found between
measured REE and FFM means FFM should become the basis for prediction REE equations in
BeMD adults. Furthermore, physical activity should be encouraged, where possible, in an
attempt to maintain FFM and reduce calorific imbalances, as well as to prevent possible car-
diovascular and respiratory health implications.
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